Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:58 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Pharmacologic Modulation of Hippocampal Activity in Psychosis
NCT04277936 · Vanderbilt University Medical Center · PHASE2 · terminated · last registry update 2021-08-05 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study was redesigned and submitted as a new protocol (NCT04559529).” | – | Registry record, Vanderbilt University Medical Center |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SV2A within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-06-27Also stopped (withdrawn): Assistance Publique Hopitaux De Marseille, Perampanel + conventional antiepileptic treatment (NCT03636958)
- 2022-05-16Results posted on the registry: University of Minnesota, levetiracetam (NCT02002819)
- 2022-03-02Phase 3 first posted: University of Southern Denmark, Rapid sedation (NCT05263674)
- 2022-02-17Results posted on the registry: Mazandaran University of Medical Sciences, Levetiracetam + Valproate (NCT03940326)
- 2021-12-30Results posted on the registry: Duke University, Lacosamide + Levetiracetam (NCT03436433)
- 2021-12-29Results posted on the registry: UCB Biopharma SRL, Padsevonil (NCT03370120)
- 2021-12-29Also stopped (terminated): UCB Biopharma SRL, Padsevonil (NCT03370120)
- 2021-12-15Results posted on the registry: University of Florida, Levetiracetam (NCT02334722)
- 2021-11-26Results posted on the registry: UCB Biopharma S.P.R.L., Brivaracetam (NCT03405714)
- 2021-11-23Results posted on the registry: Kite, A Gilead Company, Axicabtagene Ciloleucel + Fludarabine (NCT02348216)
- 2021-11-16Also stopped (withdrawn): University of South Florida, levetiracetam + Placebo (NCT00584025)
- 2021-11-05Phase 3 first posted: UCB Biopharma SRL, Brivaracetam Film-coated tablet + Brivaracetam oral solution (NCT05109234)
- 2021-10-25Results posted on the registry: UCB Biopharma SRL, Padsevonil + Placebo (NCT03739840)
- 2021-07-28Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil (NCT04136444)
- 2021-07-28Also stopped (terminated): UCB Biopharma S.P.R.L., Padsevonil (NCT04136444)
- 2021-07-12Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil (UCB0942) + Erythromycin (NCT03480243)
- 2021-07-08Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil (NCT04075409)
- 2021-06-30Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil (NCT04013191)
- 2021-06-24Results posted on the registry: UCB Biopharma SRL, Padsevonil + Microgynon 30® (NCT04131517)
- 2021-06-24Also stopped (terminated): UCB Biopharma SRL, Padsevonil + Microgynon 30® (NCT04131517)
- 2021-06-18Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil + Moxifloxacin (NCT04126343)
- 2021-06-18Also stopped (terminated): UCB Biopharma S.P.R.L., Padsevonil + Moxifloxacin (NCT04126343)
- 2021-06-18Results posted on the registry: UCB Biopharma S.P.R.L., Padsevonil + Placebo (PSL) (NCT04039919)
- 2021-06-18Also stopped (terminated): UCB Biopharma S.P.R.L., Padsevonil + Placebo (PSL) (NCT04039919)
- 2021-05-17Results posted on the registry: Janssen Research & Development, LLC, Topiramate + Levetiracetam (NCT02201251)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision